15% fall discount applied automatically at checkoutFree USA shipping over $100Free worldwide shipping over $200
Sign in 0

Retatrutide 5mg

$79.99 or subscribe for $67.99/mo

Lot PL-2609-081 tested in our lab: 99.33% purity by HPLC Certificate PL-26-00081, analysed Sep 19, 2026 · LC-MS identity, endotoxin and sterility on the certificate · details and COA images
Third-party testing guarantee. Have this product tested by any independent laboratory. If the result does not come back as the compound named on the label, at the purity and amount stated, we refund your order in full and reimburse the cost of the test. Email the lab report and your order number to michael@prymalab.net.
Safety data sheet PL-SDS-140 GHS: Warning · H361 · Read the SDS · PDF

Visa, Mastercard, Discover up to $1,000 per order (charged in MXN; your bank may add a foreign-transaction fee). Pay by Bank, Zelle, Cash App or crypto: 10% off.

Retatrutide 5 mg: the smallest fill of LY3437943, a lipidated GIP, GLP-1 and glucagon receptor agonist peptide, as freeze-dried powder in a sealed vial. Tested in PrymaLab’s own laboratory, with a lot certificate. Laboratory research use only.

Description

PrymaLab · Research use only

Retatrutide 5mg

The smallest retatrutide fill: 5 mg of lyophilized LY3437943 in one vial

Retatrutide, coded LY3437943 in the early papers, is a lipidated peptide designed to act on the GIP, GLP-1 and glucagon receptors together. The 5 mg vial is the smallest fill in the range and holds white lyophilized powder under its own lot number. Published work covers how the molecule was designed, its receptor activity, mouse studies and clinical trials in obesity, diabetes and liver fat, all with an investigational drug.

Specifications

Retatrutide 5mg at a glance
Property Value
Compound Retatrutide LY3437943; GIP/GLP-1/glucagon receptor triple agonist
CAS number 2381089-83-2
Molecular formula C221H342N46O68
Theoretical mass 4731.4 Da
Sequence / structure H-Y-Aib-QGTFTSDYSI-[αMeLeu]-LDKK(AEEA-γGlu-C20 diacid)AQ-Aib-AFIEYLLEGGPSSGAPPPS-NH₂ (39 residues; Aib2, α-methyl-Leu13, Aib20; Lys17 acylated with eicosanedioic acid via γ-Glu and AEEA; C-terminal amide)
Label claim 5 mg/vial
Form Lyophilized (freeze-dried) powder or cake in a sealed glass vial with a rubber stopper and aluminium crimp cap
Storage, sealed −20 °C, desiccated, dark
Purity specification 99.0% or higher by RP-HPLC
Lot certificate Results for the lot now shipping are in the certificate panel on this page
Safety data sheet PL-SDS-140

Other fills

This is the 5 mg fill. The Retatrutide 10mg page is the main listing for this compound, with the full research summary and every fill side by side. Other fills: 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg.

What the research covers

The discovery paper by Coskun and colleagues reported that LY3437943 activates the GLP-1 and glucagon receptors to a similar degree and the GIP receptor more strongly1. In obese mice it lowered body weight and improved glycaemic control, and the authors credited part of the weight effect to higher energy expenditure through the glucagon receptor1. They judged that these results, with an early phase 1 study, warranted further clinical work1. The phase 2 trials and the open questions are summarised on the retatrutide 10 mg page.

The Retatrutide vs Tirzepatide guide covers the literature in more depth.

How each lot is tested

Every lot is tested in PrymaLab’s own laboratory in Ashland, Kentucky before release: RP-HPLC for purity, LC-MS for identity, Karl Fischer titration for water, LAL for endotoxin and USP <71> for sterility. The results for the lot now shipping are in the certificate panel on this page, and the certificate number, key and QR code can be checked on the verify page. These are in-house results from PrymaLab Analytical, not an independent test, and the lab is not accredited to ISO 17025. The third-party testing guarantee on this page still applies: if any independent laboratory finds the wrong compound, or less than the stated purity or amount, the order is refunded and the cost of the test is reimbursed.

Frequently asked questions

How much retatrutide is in a 5 mg vial in molar terms?

About 1.06 µmol, using the theoretical mass of 4731.4 Da given on the certificate. The real figure is a little lower because freeze-dried powder holds some residual water, which the certificate reports as a percentage for each lot.

Is the 5 mg fill tested separately from the larger vials?

Yes. Each fill is produced and released as its own lot. The 5 mg vial has a separate lot number and certificate, and the panel on this page shows the results for the 5 mg lot currently shipping.

References

  1. Coskun T, Urva S, Roell WC, et al. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept. Cell Metab. 2022;34(9):1234-1247.e9. DOI · PubMed

Research use only

For laboratory research use only. Retatrutide 5mg is not a drug, food, cosmetic or dietary supplement, is not approved by the FDA or any comparable authority for human or veterinary use, and must not be given to people or animals. It is sold to qualified researchers and institutions, and the buyer is responsible for lawful handling and disposal.

Other formats of Retatrutide

Retatrutide is also stocked as Retatrutide 15mg preloaded 3ml pen. Each listing states its own quantity and concentration, and the pen and vial comparison explains what changes between formats. The retatrutide buying guide covers what to check on a certificate before ordering.

Additional information

Weight 0.1 lbs
Dimensions N/A

Lot PL-2609-081 · Certificate of Analysis PL-26-00081

Every lot is tested in our own laboratory before it ships. These are the reference facts for this compound and the results for the lot currently shipping. Open the certificate page to verify it by QR code or number.

CompoundRetatrutide
LY3437943; GIP/GLP-1/glucagon receptor triple agonist
CAS number2381089-83-2
Molecular formulaC221H342N46O68
Theoretical mass4731.4 Da
Sequence / structureH-Y-Aib-QGTFTSDYSI-[αMeLeu]-LDKK(AEEA-γGlu-C20 diacid)AQ-Aib-AFIEYLLEGGPSSGAPPPS-NH₂ (39 residues; Aib2, α-methyl-Leu13, Aib20; Lys17 acylated with eicosanedioic acid via γ-Glu and AEEA; C-terminal amide)
AppearanceWhite lyophilized powder
Storage−20 °C, desiccated, dark
Label claim5 mg/vial
Lot numberPL-2609-081
Certificate numberPL-26-00081
Date of analysis2026-09-19 (retest 2028-09-18)
Purity (RP-HPLC)99.33%
Identity (LC-MS)4731.5 Da
Water content (KF)1.4%
Endotoxin (LAL)0.05 EU/mg
SterilityNo growth; conforms
ConclusionPASS
Tested byPrymaLab Analytical (PrymaLab's own laboratory, Ashland, KY). In-house result, not an independent third-party test.
Third-party testing guarantee. Have this product tested by any independent laboratory. If the result does not come back as the compound named on the label, at the purity and amount stated, we refund your order in full and reimburse the cost of the test. Email the lab report and your order number to michael@prymalab.net.
Certificate of analysis for lot PL-2609-081, page 1
Certificate page 1: results
Certificate of analysis for lot PL-2609-081, page 2
Certificate page 2: method and approval

Safety data sheet PL-SDS-140 · Retatrutide

GHS safety data sheet for this product (lyophilized powder, vial), revision 1.0 of October 3, 2026. Read all 16 sections or download the PDF to keep with the material.

Warning
  • H361 Suspected of damaging fertility or the unborn child.
CompositionRetatrutide (CAS 2381089-83-2) · ≥ 95% (dry basis, as supplied), 5 mg, 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg per vial
ClassificationReproductive toxicity (Category 2)
Physical stateSolid. White to off-white lyophilized powder.
Storage−20 °C (sealed vial), desiccated and protected from light; 2–8 °C acceptable for short periods
HandlingOpen vials only in a clean area. Avoid generating or inhaling dust; weigh or reconstitute inside a ventilated enclosure when the full contents are handled as a dry powder. Reconstitute by adding diluent slowly to the vial wall; do not shake. Wash hands after handling.
First aidEyes: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do; continue rinsing. If eye irritation persists, get medical advice. Skin: Take off contaminated clothing. Wash the skin with plenty of soap and water. If irritation or a rash develops, get medical advice. Ingestion: Rinse mouth. Do not induce vomiting. Call a POISON CENTER or doctor if you feel unwell.
DisposalChemical waste through a licensed contractor; do not pour down the drain.
TransportNot regulated as a dangerous good (DOT / IATA / IMDG).

For laboratory research use only. Not for human or veterinary use.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Peptide Research Articles

24-hour support icon
24/7 Online support

support@prymalab.net info@prymalab.net

Quality guarantee badge icon
7-day returns

7-day returns on unopened, sealed products, plus our third-party testing guarantee.

Shipping truck icon
Free US shipping

Free USA shipping over $100 and free worldwide shipping over $200.

RealReviews.io Rate your experience with PrymaLab